TOP TIERMARKET NEWSWIRE
News & sentiment

JASPER THERAPEUTICS (JSPR) — News & AI sentiment

JASPER THERAPEUTICS (JSPR) news roundup. 14 stories aggregated over the last 30 days. Average 30-day sentiment is 51.9/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
14
avg sentiment 51.9/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

JSPR news in the last 24 hours, 7 days, 30 days and 90 days

How much JSPR coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowJSPR storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days1451.9/100JSPR headlines →
Last 90 days3454.4/100JSPR headlines →

Latest stories on JSPR

Oct 15
Oct 15
Oct 15
Oct 14
William Blair resumes Jasper Therapeutics stock with outperform rating
Investing.com Analyst Ratings63 · neutralanalyst
Oct 14
Oct 14
Oct 7
Oct 7
Oct 7
Oct 7
Oct 5
Oct 2
Oct 1
Sep 28
Sep 15
Sep 15
Sep 9
Sep 9
Sep 3
Sep 1
Sep 1
Aug 26
Jasper Therapeutics stock rating reiterated at Buy by H.C. Wainwright
Investing.com Analyst Ratings61 · neutralanalyst
Aug 18
Aug 17
Aug 17
Open JSPR in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →